Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Toll-like receptor 7 (human) monoclonal antibody (4F4)

 
ALX-804-654-R100 100 µl 378.00 USD
Do you need bulk/larger quantities?
 

Product Specification

Alternative Name:TLR7
 
Clone:4F4
 
Host:Mouse
 
Isotype:IgG1 κ
 
Immunogen:Recombinant human TLR7 (Toll-like receptor 7) (aa 451-500).
 
UniProt ID:Q9NYK1
 
Species reactivity:Human
 
Applications:ELISA, WB
 
Recommended Dilutions/Conditions:Western Blot (1:500-1:2,000)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
 
Purity Detail:Protein G-affinity purified.
 
Formulation:Liquid. In PBS, pH 7.4, containing 0.1% sodium azide.
 
Use/Stability:Stable for 1 month when stored at +4°C.
 
Handling:Avoid freeze/thaw cycles.
 
Shipping:Shipped on Blue Ice
 
Short Term Storage:+4°C
 
Long Term Storage:-20°C
 
804-654
Figure: Western blot analysis using MAb to Toll-like Receptor 7 (human) (4F4) (Prod. No. ALX-804-654). Method: Ramos cell lysate (80μg) was resolved by SDS-PAGE, transferred to PVDF membrane and probed with MAb to Toll-like Receptor 7 (human) (4F4) (1:1’000). Proteins were visualized using a goat anti-mouse secondary antibody conjugated to HRP and an ECL detection system. Arrow indicates TLR7 in human Ramos cells.
Please mouse over
804-654

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
TLR
TLR7
By biological activity:
TLR Monoclonal antibody
TLR7 Monoclonal antibody
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Related Literature

Product Flyers
Antiviral Signaling
Antiviral Signaling
Download as PDF

Product Flyers
Key TLR Ligands and their Receptors
Key TLR Ligands and their Receptors
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,